首页 | 本学科首页   官方微博 | 高级检索  
     


Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events
Authors:Romain Chopard  Guillaume Serzian  Sébastien Humbert  Nicolas Falvo  Mathilde Morel-Aleton  Benjamin Bonnet  Gabriel Napporn  Elsa Kalbacher  Laurent Obert  Bruno Degano  Gilles Cappelier  Yves Cottin  François Schiele  Nicolas Meneveau
Affiliation:1.Department of Cardiology, EA3920,University Hospital Besan?on,Besan?on,France;2.Department of Internal Medicine,Hospital Besan?on,Besan?on,France;3.Department of Internal Medicine,University Hospital,Dijon,France;4.Department of Cardiology,General Hospital,Pontarlier,France;5.Department of Cardiology,General Hospital of Vesoul,Vesoul,France;6.Department of Cardiology,Hospital Center Louis Pasteur,Dole,France;7.Medical Oncology Unit,University Hospital Besan?on,Besan?on,France;8.Orthopedic, Trauma, Plastic, Reconstructive and Hand Surgery Department,University Hospital Besan?on,Besan?on,France;9.Department of Physiology, EA3920,University Hospital Besan?on,Besan?on,France;10.Medical Intensive Care Unit, EA3920,University Hospital Besan?on,Besan?on,France;11.Department of Cardiology,University Hospital,Dijon,France
Abstract:Dose adjustment of direct oral anticoagulants (DOACs) is not required in the setting of acute PE treatment according to the manufacturer’s labelling, beyond the contraindication in severe renal insufficiency. We designed a prospective, multicenter cohort study to investigate the impact of prescription of non-recommended DOAC doses on 6-month adverse events. The primary endpoint was a composite of all-cause death, recurrent VTE, major bleeding, and chronic thromboembolic pulmonary hypertension (CTEPH). In total, among 656 patients discharged with DOACs between 09/2012 and 10/2016, 28 (4.3%) were not treated with a recommended DOAC dose. All the non-recommended DOAC dose prescriptions were under-dosed according to the drug labelling. After multivariate adjustment, age?>?70 years, a history of coronary artery disease, creatinine clearance?
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号